PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'GHU Paris Psychiatrie et neurosciences, Service de Neuroanesthésie Neuroréanimation, Paris, France. a.mazeraud@ghu-paris.fr.\', \'Univeristé de Paris, Paris, France. a.mazeraud@ghu-paris.fr.\', \'GHU Paris Psychiatrie et neurosciences, Service de Neuroanesthésie Neuroréanimation, Paris, France.\', \'Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brasil.\', \'GIRCI-IDF, Cellule Méthodologie, Paris, France et Université Paris-Saclay, UVSQ, Inserm, Équipe d\'Épidémiologie respiratoire intégrative, CESP - Centre de recherche en Epidémiologie et Santé des Populations U1018 INSERM UPS UVSQ, Villejuif, France.\', \'CH Sud-Essonnes, Service de Réanimation, Etampes, France.\', \'Univeristé de Paris, Paris, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13063-021-05118-7
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 33648563
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all